Merck Snaps Up Autoimmune-Focused Pandion in Massive $1.85 Billion Deal
Merck said the acquisition adds a pipeline of drug candidates that target a broad range of autoimmune diseases.
Create a job alert and receive custom job recommendations straight to your inbox.
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.